AIR Teaming Profiles
This page is designed to help facilitate connections between prospective proposers, which ARPA-H anticipates will be necessary to achieve the goals of the Autonomous Interventions and Robotics (AIR) program. Prospective performers are encouraged (but not required) to form teams with varied technical expertise to submit a proposal.
If either you or your organization are interested in teaming, please create a profile via the ARPA-H Solutions Portal linked below. Your details will then be added to this page, which is publicly available.
Please note that by publishing the teaming profiles list, ARPA-H is not endorsing, sponsoring, or otherwise evaluating the qualifications of the individuals or organizations included here. Submissions to the teaming profiles list are reviewed and updated periodically.
AIR Teaming Profiles
To narrow the results in the Teaming Profiles List, please use the input below to filter results based on your search term. The list will filter as you type.
| June Lee, MD, PhD | NSMS | Dr.JuneLee@nsmsusa.org | Bethesda, MD | Since our founding on March 22, 1996, the National Society of Medical Scientists (NSMS) has been dedicated to defining the future of healthcare science, technology, and development in the United States. Our members are clinicians (Neurosurgeons, Interventional Radiologists) with deep expertise in defining clinical requirements, designing prospective clinical trials, establishing safety protocols, and validating autonomous medical devices, including AI-driven systems. Focus on robotics/microbots. | We seek partners with strong capabilities in Robotics Engineering (for TA1 actuation/navigation), Control Systems, Algorithm Development (for autonomous decision-making under uncertainty/UQ), and Microbot Fabrication/Propulsion (for TA2). We offer clinical expertise, access to realistic phantom/cadaver labs, and a pathway to FDA-compliant trial design. | TA2: Microbots, TA1: Endovascular Robotics |
| Mark Palmer | Synopsys, Inc | mark.palmer@ansys.com | Sunnyvale, CA | At Synopsys we have over 50 years of experience in technologies that enable highly scalable, virtual design and testing processes. Our research captures EDA, Silicon IP, physics, and physiology in software to provide tools to accelerate innovation. We generate synthetic data governed by the laws of physics and physiology to train AI. This enables the deployment of a software ecosystem and digital twins ranging from edge to cloud supporting your innovation in the physical world. | Our ideal partners work collaboratively with us to accelerate their product lifecycle with digital design processes applied to simulated patient cohorts. The collaboration results in data to support optimum patient selection, support for regulatory submission, and deployment of software ecosystem that supports your innovation. The ideal partner will lead the engagement with the market while Synopsys provides background support, automation, and infrastructure to enable their market goals. | TA1: Endovascular Robotics, TA2: Microbots |
| Andinet Enquobahrie | Kitware | andinet.enqu@kitware.com | Carrboro, NC | Kitware advances surgical simulation through integrated platforms that combine imaging, visualization, simulation, and physiological modeling using our open-source tools (VTK/ITK/3D Slicer/Pulse/ParaView). We build custom virtual training environments featuring validated cardiovascular physiology, haptic-enabled device mechanics, and advanced X-ray fluoroscopic image generation solutions. Kitware has experience both as a performer on large DARPA and ARPA-H programs. | (1) Robotics partner for co-development and validation, (2) High volume stroke center with neurovascular datasets and endovascular procedure expertise, and (3) Real-time tool-tissue interactions and real-time fluid simulations. | TA1: Endovascular Robotics |
| Hongsoo Choi | University of Massachusetts Amherst | hongsoochoi@umass.edu | Amherst, MA | I develop magnetically controlled microrobotic guidewires, catheters, and electromagnetic/VR-enabled control systems that provide precise, real-time navigation for neuro- and cardiovascular interventions. With over 10 years of innovation and extensive in vivo validation in swine, my work actively advances steerable microrobots that can serve as the foundation for autonomous thrombectomy and next-generation microbotic interventions, expanding access to life-saving care. | We seek partners with expertise in regulatory strategy, commercialization, and advanced imaging (C-arm, biplane, fluoroscopy). We also need stroke specialists and hospitals capable of swine studies and willing to install our microrobotic systems, plus surgical navigation and AI experts to enhance autonomous microrobot guidance for future human translation. | TA1: Endovascular Robotics, TA2: Microbots |
| Jung-eun Park | XCath | jungeun.park@xcath.com | Huston, TX | XCath is advancing neurovascular intervention robotics by developing a highly precise, stable, and responsive robotic platform designed for navigating complex cerebral vasculature. Current research focuses on improving robotic manipulation, haptic safety mechanisms, real-time procedural visualization, and seamless integration with clinical imaging systems to enhance accuracy, consistency, and overall procedural performance. | We seek TA1-B partners who can build a high-fidelity endovascular simulation and imaging resource for our neurovascular intervention robot. Ideal partners develop in silico vascular and clot models, realistic fluoroscopy simulators, and large CTA/fluoro datasets, and can integrate their virtual testbed with our robotic platform and FDA-aligned validation workflows. | TA1: Endovascular Robotics |
| Igor Aronson | Pennsylvania State University | isa12@psu.edu | University Park, PA | We are developing microscopic robots powered by enzymatic reactions. The autonomous robots can deliver a payload (e.g., a drug) into the desired location оr report a chemical of interest (e.g., a contaminant or signaling molecule). Fabricating enzyme-propelled and acoustically/magnetically propelled microrobots for cargo delivery. | We are looking for partners with expertise in particle synthesis and enzyme-mediated functionalization. Possible technologies include 3D nanoprinting and additive manufacturing. Experience in medical applications. | TA2: Microbots, TA1: Endovascular Robotics |
| John Sadowski | Planned Systems International | Jsadowski@atlintl.com | Washington, DC | We are a global health IT solutions provider with a track record in both ARPA-H execution and clinical integration. PSI specializes in predictive modeling using AI, and has 5 patents on robotic autonomous healthcare. We own a lightweight electronic health record system utilized by the federal government, and have existing contracts with the U.S. Defense Health Agency and the VA. PSI has already won ARPA-H contracts, which can significantly de-risk aspects of potential partners' solutions. | We are seeking to partner with organizations that have the expertise for the technical robotics and bioscience aspects of the program. | TA2: Microbots, TA1: Endovascular Robotics |
| Sameer Sonkusale | Tufts University | sameer.sonkusale@tufts.edu | Boston, MA | Relevant expertise: Miniaturized chemical/biological sensors to guide catheters or microbots, Controlled delivery of cargo such as embolic agents or drugs, Micro and nanofabrication, Device fabrication, Control and communication. Miniaturized pressure flow and temperture sensors, Implantable chemical and biosensors, Power Considerations; Integrated Circuits and Instrumentation. | for TA1 - Catheter/Guidewire, fluoroscopy, clinical collaborator. For TA2 - motion, planning, mechatronics aspects for biopsy or ablation, clinical collaborator Robotics; Clinical Expertise; | TA2: Microbots, TA1: Endovascular Robotics |
| Jithesh Veetil | Medical Device Innovation Consortium (MDIC) | jveetil@mdic.org | Arlington, VA | We operate as a public-private partnership that accelerates the development and access to medical technologies by bringing together industry, the FDA, and patient groups. MDIC focuses on improving regulatory science, manufacturing quality, and incorporating patient preferences through initiatives like the "Case for Quality", "Patient-Centered Benefit-Risk Assessment" and such programs. | Broader coalition in the MedTech ecosystem to make greater impact. | TA1: Endovascular Robotics, TA2: Microbots |
| Ryan Sochol | University of Maryland, College Park | rsochol@umd.edu | College Park, MD | Building steerable, fluidically actuated soft robotic microcatheters and guidewires via two-photon 3D micro/nanoprinting. | Teams that could leverage the 3D micro/nanoprinting and/or soft robotic surgical tools strategy. | TA1: Endovascular Robotics, TA2: Microbots |
| Michael Yip | UC San Diego | yip@ucsd.edu | San Diego, CA | Experts in endovascular robotics, robot hardware design, and surgical robot autonomy | Imaging Technology and Digital Twinning Partners, Clinical Scientists, Military Medicine | TA1: Endovascular Robotics |
| Abigail Cember | Rhino Federated Computing | abby@rhinofcp.com | Boston, MA | Rhino's federated computing platform allows for model training while keeping source data private; for example, models for medical robotics which must be trained on a great number of data sets arising from real human patients. We are interested in demonstrating (and improving, if need be) our platform's capability to facilitate this use case of federated learning. We do not have a preference for focusing on either microbots or endovascular robotics. | We seek to join a team of roboticists, clinicians and others, to whom we can provide the data and computational infrastructure enabling the secure training of embodied AI models on real-world data subject to rigorous privacy constraints. | TA2: Microbots, TA1: Endovascular Robotics |
| Sung Kwon Cho | University of Pittsburgh | skcho@pitt.edu | Pittsburgh, PA | developing a microrobotic powered guidewire | Medical doctors who can guide and explore direct applications of our developing system | TA1: Endovascular Robotics, TA2: Microbots |
| Youngjae Chun | University of Pittsburgh | yjchun@pitt.edu | Pittsburgh, PA | Our organization advances surgical interventions and medical devices to expand access to life-saving care. Key areas include stroke treatment via thrombectomy, minimally invasive procedures, and small-scale AIR robot development. By integrating engineering, clinical expertise, and industry collaboration, we deliver safer, more efficient, and widely accessible healthcare solutions. | Our organization seeks teaming partners with expertise in medical device development, robotics, artificial intelligence, clinical care, and engineering innovation. Ideal partners bring complementary skills, share a commitment to advancing autonomous and minimally invasive surgical solutions, and are ready to collaborate on high-impact, translational projects that improve patient outcomes and expand access to life-saving procedures. | TA1: Endovascular Robotics, TA2: Microbots |
| Xiaoguang Dong | Vanderbilt University | xgdong2013@gmail.com | Nashville, TN | Magnetic soft microrobot for drug delivery | Medical imaging partners | TA2: Microbots, TA1: Endovascular Robotics |
| Allison Okamura | Stanford University | aokamura@stanford.edu | Stanford, CA | Design and control of novel robots, learning from demonstration (including teleoperation and haptic feedback) | Autonomy expertise, clinical expertise | TA1: Endovascular Robotics, TA2: Microbots |
| Glenn Block | Synap Biotech inc. | glenn.block@synapbio.com | Norfolk, VA | Synap Biotech Inc. is a Virginia-based company developing first-in-class Intranasal Nanobody® therapies to restore the brain’s ability to repair itself after stroke, TBI, and neurodegenerative disease. Our lead program targets Nogo-A, a key blocker of neuroplasticity, using non-invasive intranasal delivery to bypass the blood–brain barrier and enable true brain repair. | Enhancing Outcomes After Autonomous Thrombectomy AIR expands access to curative thrombectomy, but restoring lost brain function still requires neuroregeneration. Synap’s Intranasal Nanobody® therapy: Promotes neuroplasticity after ischemic injury Can be administered immediately post-procedure Fits in any clinical setting (ER, stroke unit, rural hospital) Pairs perfectly with a minimally invasive intervention model APR handles the clot; Synap handles the recovery. | TA1: Endovascular Robotics, TA2: Microbots |
| Jayne Dadmun | The University of Tennessee, Knoxville | jdadmun@utk.edu | Knoxville, TN | Health innovation, research and education with flagship programs in cancer research, surgical robotics, substance abuse and data analytics. | Multi-institutional approach to enhance applications of process optimization, signal prcoessing, and robotics in surgery | TA1: Endovascular Robotics, TA2: Microbots |
| Juan Wachs | Purdue University | jpwachs@purdue.edu | West Lafayette, IN | telerobotics, autonomous robots, life saving skills, AI medics | dual robotic platforms | TA1: Endovascular Robotics, TA1: Endovascular Robotics |
| Fei Liu | University of Tennessee, Knoxville | fliu33@utk.edu | Knoxville, TN, US, TN | Our research focuses on advancing surgical robotics through physics-based modeling, embodied AI, and intelligent control. We develop computational representations of tool–tissue interaction, generative simulation frameworks, and data-driven policies that enable safer and more capable robot-assisted procedures. Our work integrates 3D vision, differentiable simulation, and learning-based control to build real-time digital twins and intraoperative assistance systems. | surgical robotics company who is working on endovascular robots | TA1: Endovascular Robotics, TA2: Microbots |
| Jindong Tan | University Of Tennessee, Knoxville | tan@utk.edu | Knoxville, TN | The University of Tennessee specializes in microbots and minimally invasive interventions. We develop autonomous and semi-autonomous robotic navigation, AI-guided control, soft and magnetic actuation, real-time imaging, and digital-twin platforms to enable precise, adaptive, and safer intravascular procedures for stroke, cancer, and cardiovascular disease. | We seek partners with complementary capabilities, rapid prototyping, regulatory experience, and pathways to real-world deployment in stroke, oncology, and cardiovascular care. | TA2: Microbots, TA1: Endovascular Robotics |
| Payam Eliahoo | Radioson Corporation | peliahoo@radiosoninc.com | Los Angeles, CA | Robotic surgery | clinicians | TA1: Endovascular Robotics, TA2: Microbots |
| Wei Gao | California Institute of Technology | weigao@caltech.edu | Pasadena, CA, CA | The Gao Lab is working on the design of microrobots powered by bioavailable fuels or externally applied fields such as ultrasound and magnetic fields. These systems enable a range of sophisticated capabilities, including biosensing, targeted drug delivery, precision surgery, bioimaging, and cellular isolation. | Clinical partners for evaluation of the micro/nanorobotics; experts with advanced remote imaging and control expertise. | TA2: Microbots |
| HAN-PANG CHIU | SRI International | han-pang.chiu@sri.com | Princeton, NJ | SRI Center for Vision Technologies has a long history in autonomous navigation with small mobile platforms and devices. Recently, we have created novel technologies to ground foundation models for generating navigation plans and medical procedure guidance under multiple government programs. We also have state-of-the-art data augmentation and generative AI techniques which can be used to increase realism and variation in the training data and simulation. | We are looking for medical partners, with expertise in the medical devices and procedures related to TA1. | TA1: Endovascular Robotics, TA2: Microbots |
| Jundong Li | University of Virginia | jundong@virginia.edu | Charlottesville, VA | Our work spans from foundational algorithm design to practical predictive models that integrate complex structured data and real-world signals, and we have deep expertise in building scalable and reliable AI models suitable for resource-constrained environments. | We seek to join a multidisciplinary team that would benefit from advanced AI and computational modeling expertise, particularly in areas such as multimodal model development, predictive decision support, robust and trustworthy learning algorithms, and scalable inference on edge or autonomous systems. We are especially interested in collaborating where AI/ML can provide the core reasoning, prediction, or safety-critical analytics component within a larger robotic, sensing, or clinical platform. | TA1: Endovascular Robotics, TA2: Microbots |
| Luke Beardslee | University of Maryland | labeardslee04@gmail.com | Maryland USA, MD | Ingestible, wearable and implantable sensors and actuators | Integrated Circuits Expertise, Animal Testing Expertise, Wireless Energy Transfer | TA2: Microbots, TA1: Endovascular Robotics |
| Rani Elhajjar | University of Wisconsin-Milwaukee | elhajjar@uwm.edu | Milwaukee, WI | Our team excels in smart materials and composites, with expertise in magnetostrictive composties, PVDF and fiber optic strain sensors. For TA1, we enable real-time force feedback for safer navigation. For TA2, we support miniaturized, sensor-integrated microbots for precise actuation. We seek collaborators to advance autonomous medical interventions. | Embedded sensing, material-response modeling, and experimental validation | TA1: Endovascular Robotics, TA2: Microbots |
| Jacob Biehl | University of Pittsburgh | jacobbiehl@pitt.edu | Pittsburgh, PA | Our research focuses on autonomous endovascular robotics through reinforcement learning for catheter/guidewire control, real-time extraction of tool configuration, and live registration between pre-operative anatomy and intraoperative imaging to support navigation. We also study human-factors challenges in spatial perception and interface design to inform safe, fully autonomous thrombectomy and embolization workflows. | We are looking for partners with strong capabilities in robotic hardware, clinical translation, and regulatory strategy. Our team has built custom instruments and sensing platforms for evaluating our methods, but would benefit from collaboration with groups more experienced in scalable device engineering, verification/validation, and clinical deployment. | TA1: Endovascular Robotics |
| Giovanni Pittiglio | Worcester Polytechnic Institute | gpittiglio@wpi.edu | Worcester, MA | Our autonomous robot uses contact-aware planning and control to maintain stable, precise tool interaction in dynamic environments. By predicting contact forces and adapting motion in real time, it ensures consistent performance even under uncertainty. This enables safer, more reliable manipulation for demanding tasks where accuracy and stability are critical. | We seek teaming partners with strengths in medical image registration, multimodal image fusion, and advanced image analysis. Ideal collaborators bring expertise in deformable registration, MRI/CT angiographic processing, and quantitative anatomical mapping, as well as experience building scalable pipelines, validating algorithms on clinical datasets, and translating imaging tools into interventional workflows. | TA1: Endovascular Robotics |
| Pallavi Tawde | Synap Biotech | pallavi.tawde@synapbio.com | San Francisco, CA | Synap Biotech is developing a first-in-class Anti-Nogo-A Nanobody® immunotherapy for stroke to counter Nogo-A, the key blocker of neuroplasticity. To overcome the blood brain barrier (BBB) challenge, we plan to use intranasal delivery to bypass the BBB and deliver our Nanobody® therapy directly to the brain. This proven novel and non-invasive delivery approach is designed to deliver the Nanobody® therapy to its intended target and maximize therapeutic impact. | Collaborate and work together with stroke robotics for targeted therapies. | TA2: Microbots, TA1: Endovascular Robotics |
| Young-Ho Kim | Siemens Healthineers | young-ho.kim@siemens-healthineers.com | Princeton, NJ | We focus on AI-driven image-to-action automation across X-ray/fluoro, ultrasound, CT, and MRI. Our work spans multimodal perception, autonomous view navigation, tool/tip tracking, therapy safety guarding, and predictive catheter control under X-ray for motion-aware view planning. We also advance multi-agent path planning and trajectory optimization. These capabilities underpin our Auto-Copilot framework, enabling end-to-end clinical procedure automation. | We seek partners with expertise in micro-scale interventional devices, including magnetically assisted micro-tools or controllable micro-actuators that can operate within vascular or confined anatomical environments. Ideal collaborators contribute novel device designs or actuation methods for fine-scale manipulation. We aim to combine such innovations with Siemens’ AI-based image-to-action autonomy for next-generation closed-loop interventions. | TA2: Microbots, TA2: Microbots |
| Emily Shaw | Mentice | emily.shaw@mentice.com | 820 W Jackson Blvd, Ste 250 Chicago, IL | Mentice | Mentice has developed an anatomical software physics engine, combined with haptic-enabled hardware solutions, creates the optimal environment for procedural adoption, proficiency-based training, patient-specific simulation, and objective skills assessment. Over 350 development years of engineering have created the most advanced IGIT simulation solutions on the market. | TA1: Endovascular Robotics, TA1: Endovascular Robotics |
| Madison Clark-Turner | Charles River Analytics | mclarkturner@cra.com | Cambridge, MA | Charles River Analytics brings 40 years of software and AI innovation, extensive DARPA, ARPA-H, Navy, and Army experience, and deep CCC expertise, including DARPA Triage Challenge work, robot-assisted CASEVAC, and autonomous BVM placement. We deliver advanced perception, sensing, and inference for robust medical and robotic systems. | We seek partners with robotic endovascular tools, advanced sensing, and stroke/thrombectomy expertise. We are open to being a subcontractor providing advanced perception and control technologies, or prime leveraging our agile small-business structure and strong DARPA history to lead programmatics, integration, and customer engagement. | TA1: Endovascular Robotics |
| Chris Mattmann | Mattmann.AI, LLC | chris@mattmann.ai | Los Angeles, CA | . Mattmann.AI’s open source work includes the development of and contribution to Apache software including Spark, Tika, Nutch, Solr, Elasticsearch, Hadoop, and many other products funded by various sponsors over decades. Software it has created has been downloaded millions of times by thousands of companies around the world. | Looking to partner with trauma surgeons, medical professionals to bring AI/ML expertise and robotic expertise. | TA1: Endovascular Robotics, TA2: Microbots |
| Renee Zhao | Stanford University | rrzhao@stanford.edu | Stanford, CA | Stanford Zhao Lab recently developed a novel milli-spinner thrombectomy mechanism for stroke treatment (Nature, 2025 https://www.nature.com/articles/s41586-025-09049-0) and endovascular magnetic milli-spinner for robotic endovascular surgery (Adv. Mater. 2025 https://advanced.onlinelibrary.wiley.com/doi/full/10.1002/adma.202508180). This work developed a platform utilizing a spinning magnetic field to effectively navigate the untethered milli-spinner to the clot and to effectively debulk it. | Robotic motion control, robotic control with fluoroscopy integration | TA1: Endovascular Robotics, TA2: Microbots |
| Kihan Park | University of Massachusetts Dartmouth | kihan.park@umassd.edu | Dartmouth, MA | Biocompatible Light-controlled Multifunctional Microbots for Single-cell Therapy and Targeted Drug Delivery | 1. Medical professionals who can validate the the effectiveness of the procedures and results 2. Multidimensional endovascular robotic systems integrated with the encapsulated micro-/nano- drug carriers. | TA2: Microbots, TA1: Endovascular Robotics |
| Rui Li | New York University | rui.li@nyu.edu | New York City, NY | Interventional Radiology, Minimally Invasive Surgery, Soft Robotics, Flexible Robotics | Clinicians, Medical Enterprise, and AI company | TA1: Endovascular Robotics, TA2: Microbots |
| Nick Damiano | Andromeda Surgical | nick@andromedasurgical.com | San Francisco, CA | Autonomous endoluminal robots | We have a robotic platform and AI capabilities. Looking to partner with teams who have interventional devices that can integrate with our robot. | TA1: Endovascular Robotics |
| Al Mashal | Current Surgical Inc. | al@currentsurgical.com | Washington, DC, DC | Our company has the capability to develop (hardware, software, algorithms) small ultrasound transducer arrays that can be integrated into endovascular devices. These devices can be used to both image and deliver therapeutic energy. Our teams is composed of robotics, ultrasound , mechanical, fluidics, deep learning, and electronics experts. | We are looking for teams with strong clinical understanding of various problem domains and facilities for preclinical/clinical studies. | TA1: Endovascular Robotics, TA1: Endovascular Robotics |
| Richard Leparmentier | Imperative Care | rleparmentier@teloshealth.com | Campbell, CA | With over 80,000 procedure completed, Imperative Care long term goals is the development of a purpose-built robotic-assisted aspiration thrombectomy system: 1) to streamline cerebral reperfusion technique by integrating robotic 2) to help improve access to care for the 80% of American stroke patients who do not live close to a thrombectomy-capable hospital. 3) Automate the procedures to enable easier and faster stroke treatment. | We are looking for partners who could help us in the development of automation building blocks: 1) Anatomy mapping, segmentation 2) Pre-op to Intraop imaging registration 2) Catheter modeling 3) Virtual rendering and simulation engine 4) Data management and data infrastructure | TA1: Endovascular Robotics |
| Mihai Duduta | University of Connecticut | mihai.duduta@uconn.edu | Hartford, CT | Soft robotics capable of operation in constrained and hazardous environments, without the limitations of tendon driven mechanisms. | Looking for clinical partners to help develop our miniaturized soft robot technology for autonomous operation. | TA1: Endovascular Robotics, TA2: Microbots |
| Scott Schoen Jr | Georgia Tech | scottschoenjr@gatech.edu | Atlanta, GA | Diagnostic ultrasonic imaging, including of microcirculation and elastic properties. | Need for novel ultrasound imaging or theranostic tools (e.g., radiation force, hyperthermia, ablation) | TA2: Microbots, TA1: Endovascular Robotics |
| Hakan Ceylan | Mayo Clinic | ceylan.hakan@mayo.edu | Scottsdale, AZ | We have 10+ years of expertise in developing untethered miniature robots, ranging from sub-10 mm to cell scale, to address key unmet needs in minimally invasive therapy and diagnostics. My lab unites soft robotics, microfabrication, biomedical engineering, and digital-twin modeling to design and test next-generation microrobots through an integrated pipeline spanning phantoms, ex vivo tissues, and small and large-animal models. | Industrial partners and regulatory supervision. Although we currently build certain large surgical animal models, as well, additional surgical skills are always desired. | TA2: Microbots, TA1: Endovascular Robotics |
| Jeffrey Lipton | Northeastern University | j.lipton@northeastern.edu | Boston Ma, Seattle WA, MA | We produce tubular metamaterial robots that enable shape changing catheters | We are looking for experts in sensing and control to make autonomous catheters | TA1: Endovascular Robotics, TA2: Microbots |
| Yash Chitalia | University of Louisville | yash.chitalia@louisville.edu | Louisville, KY | The PI works on the design, mechanical modeling and control systems for micro-scale and meso-scale continuum robots. These include endonasal endoscopic laser-based diagnostic and therapeutic robots for tumors in the brain. Similarly, the PI has designed a robotic placement device for epidural spinal cord stimulators. Previously, the PI had extensive experience in designing robotically steerable guidewires and catheters as small as 0.3 mm in diameter (0.014 guidewire). | We are looking for medical expertise, and expertise in robotic navigation. | TA1: Endovascular Robotics, TA2: Microbots |
| Peter Finley | UNandUP | psf@unandup.com | Saint Louis, MO | UNandUP develops magnetically guided interventional platforms for stroke and cardiovascular disease, including ThromBot: a magnet-steered neurothrombectomy catheter and console designed to extend safe, rapid clot removal to more hospitals. Our work spans catheter and magnet hardware, in vitro/in vivo stroke models, thrombolytic/magnetic nanoparticles, and early steps toward semi-autonomous image-guided navigation. | We seek partners with deep expertise in: (1) medical robotics and autonomy (planning, control, safety) for endovascular procedures; (2) AI/ML for vascular imaging, segmentation, and guidance; and (3) clinical stroke trial operations. We bring deep experience including magnet-based system, Interventional devices, preclinical models, and regulatory affairs. | TA1: Endovascular Robotics, TA2: Microbots |
| Tomas Baltrunas | Inovatyvi Medicina | tomas.baltrunas@gmail.com | Kaunas, Lithuania | Endovascular robot Sentante enabled fully robotic endovascular procedures and transatlantic remote interventions. Our next step - fully automatic procedures. | Experienced AI teams, developers of X-Ray imaging solutions | TA1: Endovascular Robotics |
| Graham Schwarz | Cleveland Clinic | Schwarg@ccf.org | Cleveland, OH | Autonomous microsurgical robotics | Cs/ engineering / MLops | TA2: Microbots, TA1: Endovascular Robotics |
| Mehran Armand | University of Arkansas | marmand@uark.edu | Fayettville, AR | The Biomechanical- and Image-Guided Surgical Systems (BIGSS) laboratory within the University of Arkansas and Johns Hopkins University focuses on developing surgical guidance systems involving novel robots, advanced imaging, and real-time assessments to improve surgical outcomes. Our research also involves defining decision processes to formalize how a surgical robot perceives its environment, predicts the effects of its actions, and selects behaviors to achieve a goal under uncertainty. | We are looking for teaming with surgeons, research institutions, and companies with prior experience in the development of robotic systems for endovascular surgery. | TA1: Endovascular Robotics, TA2: Microbots |
| Chase Cao | Case Western Reserve University | ccao@case.edu | Cleveland, OH | soft robotics, flexible and stretchable electronics, 3D/4D printing | control experts, and a medical robot industry partner | TA1: Endovascular Robotics, TA2: Microbots |
| Mahyar Fazlyab | Johns Hopkins University | mahyarfazlyab@jhu.edu | Baltimore, MD, USA, MD | Medical/Surgical Robotics, AI | We seek partners with complementary strengths in large-scale AI systems, experimental testbeds (robotics, simulation, or cyber-physical systems), and robust systems engineering. Ideal teammates bring unique datasets, validation environments, or mission-relevant expertise to support rigorous evaluation, monitoring, and control of advanced AI systems. | TA1: Endovascular Robotics, TA2: Microbots |
| Tommaso Ranzani | Boston University | tranzani@bu.edu | Boston, MA | We work on design and control of soft robots for beating heart applications. We have expertise in robot design and manufacturing, onboard actuation, and localization. | We are looking for potential teaming partners on sensing within the endovascular system and imaging | TA1: Endovascular Robotics, TA2: Microbots |
| Louis Rogowski | Applied Research Associates, Inc. | lrogowski@ara.com | Randolph, VT | Applied Research Associates, Inc. (ARA) has been developing microrobotics technology for medical and environmental applications. ARA has developed a portable magnetic-field-generating system that can actuate microbots using high frequency, high strength magnetic fields. Working with our partners at Southern Methodist University and University of Colorado Anschutz Medical Campus, we have been developing a vitreous hemorrhage treatment using hydrogel microbots for the US Army. | We are looking for additional medical researchers, animal testing facilities, and individuals with FDA knowledge. | TA2: Microbots, TA1: Endovascular Robotics |
| Henry Hess | Columbia University | hhess@columbia.edu | New York, NY | Active Nano- and Microdevices for Biomedical, Sensing and Materials Applications | Medical Expertise, complementary engineering expertise | TA2: Microbots |
| Nathan Tatum | Applied Research Associates | ntatum@ara.com | Raleigh, NC | Current work combines scientific research and engineering in the spaces of health & human safety, sensing, and physiology modeling. We previously developed the virtual testbed as part of the DARPA Triage Challenge. Our current modeling tools range from faster than real-time full-body patient assessments to highly specific cardiovascular and immune models. We want to apply our physiological modeling and health assessment expertise to explore TA1-B solutions. | Our team is seeking partners in the medical device industry with development experience surrounding the technology and algorithms in imaging devices. Access to imaging data is a plus. We are also interested in clinical expertise, especially that relating to user experience performing these types of procedures. | TA1: Endovascular Robotics |
| Milos Zefran | University of Illinois Chicago | mzefran@uic.edu | Chicago, IL | We are focusing on automating robot surgery tasks. Our team includes engineers and surgeons. Most of our work is on autonomous dissection. We use foundation model backbones to process visual scene and are in the process of developing a Vision-Language-Action model that will allow us to automate control of the robot. The main platform that we use for our work is dVRK. We have also released an open-source dataset on cholecystectomy to help advance the field. | We are seeking partners interested in exploring new hardware solutions. | TA1: Endovascular Robotics |
| Vrad Levering | Triple Ring Technologies | vlevering@tripleringtech.com | Newark, CA, CA | Triple Ring Technologies is a leading partner in developing science-driven products across medtech and life sciences. Our interdisciplinary team, including many PhDs, excels in advancing technologies to FDA approval while collaborating with academic researchers. We have engaged with ARPA-H as both subcontractors and primary awardees. We offer services for device development such as thrombectomy catheters, ingestible devices with onboard assays, and complex robotic systems. ISO 13485 certified. | We partner with innovators to solve tough problems and create new businesses. From concept to FDA submission and commercialization, we handle technology development and redesign, as well as complex system integration. We are looking for teaming partners that could use our collaborative assistance to design enabling devices and technologies while navigating the FDA regulatory pathway. We have acted as primary, subcontractor, or vendor on previous submissions. | TA1: Endovascular Robotics, TA2: Microbots |
| Justin Opfermann | PeriCor, LLC | justin@pericorllc.com | Bethesda, MD | Our organization is focused on developing percutaneous access technology and image guided endovascular therapy for pediatric and adult patients. We have pioneered the use of Micro-CMOS imaging and electromagnetic tracking for fluoro-free navigation and medical device implantation in epicardial and endovascular environments. We have received multiple small business grants for the NHLBI for minimally invasive epicardial therapies in pediatrics. | Our organization is looking for partners with expertise in endovascular device development and micro-robotics that are compatible with our existing percutaneous access and image guided control systems. The ideal partnership will blend together our organization’s access, guidance, and control systems with state-of-the-art endovascular therapies. We would also be interested in partnering with academic organizations and institutions with animal facilities. | TA1: Endovascular Robotics, TA2: Microbots |
| Vladimir Lamm | UPMC | lammv2@upmc.edu | Pittsburgh, PA | UPMC GI advances next-generation endoluminal technologies with a focus on developing autonomous systems that can replace standard colonoscopy for colorectal cancer screening. We collaborate with CMU robotics on autonomous navigation, lesion detection, and therapeutic actuation, and provide a high-volume clinical environment for rapid prototyping and first-in-human testing of robotic platforms. | We seek partners with expertise in autonomous robotics, microrobotic locomotion, advanced sensing, AI-driven navigation, and miniaturized therapeutic tools. Ideal collaborators can accelerate development of an autonomous colonoscopy platform through engineering, control systems, fabrication, and validation. We offer clinical expertise, use-case definition, and access to real-world testing environments. | TA2: Microbots, TA1: Endovascular Robotics |
| Jeffrey Berkley | Lightside Surgical Inc. | Jeff@lightsidesurgical.com | Seattle, WA | Lightside Surgical is advancing the future of trauma care by bring surgical expertise to the point of injury. Drawing upon our team's decades of experience with trauma, robotics, AI and simulation, we are developing portable systems that enable medics to stabilize critically injured patients during field evacuation. Our technology connects frontline medical providers to remote surgeons in real time, allowing for earlier intervention, guided procedures, and continuous patient monitoring. | We are looking to team with organizations that that can help us with biological systems modeling and who can help us with clinical testing and validation using mannequins and animals. We would also be interested in partnering with organizations that have experience creating AI systems to help assist with teleoperation and automation control of intravenous robots. | TA1: Endovascular Robotics, TA2: Microbots |
| Yu She | Purdue University | shey@purdue.edu | West Lafayette, IN, USA, IN | My group focus on robotic manipulation, robot control, automation, robot learning; robotics, autonomous system, tactile sensing, mechanism design | microbot, stretchable electronics; healthcare and medical experts | TA2: Microbots, TA1: Endovascular Robotics |
| Sean Taffler | Acoustiic Inc. | sean@acoustiic.com | Bellevue, WA | Acoustiic develops high density high power ultrasound arrays. We can focus energy accurately and precisely in the body, accounting for inhomogeneities in tissue and bone, to deliver variety of therapeutic effects, from low power for neuromodulation / drug activation to high power for thermal ablation / histotripsy. Initial indications are DVT using microtripsy -disrupting thrombi within vessels- but the technology is broadly applicable to all areas of the body including the brain. | We are interested in imaging partners to facilitate the integration of fluoroscopy imaging and pre-operative imaging into the development of the therapeutic model and clinical workflow. Image segmentation and rapid automated identification of occluded flow would be advantageous. | TA1: Endovascular Robotics |
| Yonas Tadesse | UT Dallas | yonas.tadesse@utdallas.edu | Richardson, TX | Our research focuses on bioinspired robotics and smart materials, including piezoelectrics, CNTs, dielectric elastomers, shape-memory alloys, electrostatic and twisted-and-coiled polymer actuators. We develop soft robots, humanoid systems, multimodal energy harvesters, mechatronic system, and advanced CAD/simulation tools, and prototype diverse actuators and sensing modalities. Our team has filed 15 patents in manufacturing and actuation, and over 130 publications. | We seek partners who bring complementary strengths in clinical insight, robotics/microfabrication, AI & simulation, pre-clinical testing, regulatory expertise, and manufacturing/integration. Ideal collaborators ( clinical experts, industry partners , hospitals, and universities) will enhance feasibility, safety, and translational impact across all phases of the AIR program. | TA2: Microbots, TA1: Endovascular Robotics |
| Chunqi Qian | Michigan State University | qianchu1@msu.edu | East Lansing, MI | Robotic surgery assisted by biosensing and imaging | Clinical partner | TA1: Endovascular Robotics, TA2: Microbots |
| Camilo Velez Cuervo | University of California, Irvine | cvelezcu@uci.edu | Irvine, CA | My research lab: Magnetic Microsystems & Microrobotics main interests include micro/nano robotics, micro/nano device fabrication, microfabrication of magnetic microsystems, magnetic micro/nanostructures, selective magnetization of micro patterns, microsystems (MEMS), biomedical microsystems, semiconductor devices and microfluidics. | We are looking to medical expertise and capability to conduct in-vitro, in-vivo experimentation with human tissue. | TA2: Microbots, TA1: Endovascular Robotics |
| Francis Creighton | UNandUP, LLC | fmc@unandup.com | St. Louis, MO | UNandUP develops magnetically guided interventional platforms for stroke and cardiovascular disease, including ThromBot: a magnet-steered neurothrombectomy catheter and console designed to extend safe, rapid clot removal to more hospitals. Our work spans catheter and magnet hardware, in vitro/in vivo stroke models, thrombolytic/magnetic nanoparticles, and early steps toward semi-autonomous image-guided navigation. | We seek partners with deep expertise in: (1) medical robotics and autonomy (planning, control, safety) for endovascular procedures; (2) AI/ML for vascular imaging, segmentation, and guidance; and (3) clinical stroke trial operations. We bring deep experience including magnet-based system, Interventional devices, preclinical models, and regulatory affairs. | TA1: Endovascular Robotics, TA2: Microbots |
| Ayusman Sen | Pennsylvania State University | axs20@psu.edu | University Park/State College, PA | Our focus area is microrobots powered chemically or by externally imposed fields (light, magnetic, acoustic). We are interested in the design of populations of active particles with distributed functionality that communicate to collectively perform complex tasks. The particles are self-powered through autonomous energy harvesting and communicate through chemical gradients. We have shown that they can target specific organelles in cells. | We are interested in teaming with biomedical researchers that are able to do in-vivo testing of the microrobots. | TA2: Microbots, TA1: Endovascular Robotics |
| William Freeman | Mayo Clinic | freeman.william1@mayo.edu | Jacksonville, FL, FL | Simulation, Telemedicine, Robotics, and eXperimental education (AI) in healthcare | Endovascular robotics expertise that pairs with Mayo Clinic Clinical-Surgical Expertise | TA1: Endovascular Robotics, TA2: Microbots |
| Lamar Mair | Quiet Raccoon Industries, LLC | quietraccoonindustries@gmail.com | Baltimore, MD | We design, build, and implement magnetic manipulation hardware. Additionally, we design and manufacture microbots ranging from tens of nanometers to several centimeters. | We are looking to collaborate with teams seeking magnetic manipulation expertise and/or assistance in designing and manufacturing microbots. | TA2: Microbots, TA1: Endovascular Robotics |
| Chengzhi Shi | University of Michigan | czshi@umich.edu | Ann Arbor, MI | Endovascular sonothrombolysis, vortex ultrasound, cavitation, intravascular ultrasound, catheterized transducers, therapeutic ultrasound | Catheter robotics, soft robotics, endovascular robotics | TA1: Endovascular Robotics |
| Max van Apeldoorn | Philips | max.van.apeldoorn@philips.com | Cambridge, MA | Intra-operative fluoroscopy devices; endovascular robotics; intraoperative image acquisition and processing algorithms; closed-loop automation algorithms for robotic guidance | Remote network and connectivity; navigation and treatment devices; pre-op navigation and treatment plans; in-silico simulation and validation; closed-loop automation algorithms for robotic guidance | TA1: Endovascular Robotics, TA1: Endovascular Robotics |
| Javad Fotouhi | Philips | javad.fotouhi@philips.com | Cambridge, MA | Intra-operative fluoroscopy devices; endovascular robotics; intraoperative image acquisition and processing algorithms; closed-loop automation algorithms for robotic guidance | Remote network and connectivity; navigation and treatment devices; pre-op navigation and treatment plans; in-silico simulation and validation; closed-loop automation algorithms for robotic guidance | TA1: Endovascular Robotics, TA1: Endovascular Robotics |
| Raj Shekhar | Children's National Hospital | rshekhar@childrensnational.org | Washington, DC | Image fusion based surgical visualization and navigation | Robotics expertise | TA2: Microbots, TA1: Endovascular Robotics |
| Ya Wang | Texas A&M University | ya.wang@tamu.edu | College Station, TX | We develop autonomous, magnetically actuated micro-robots for endovascular and neurovascular interventions, integrating sub-millimeter helical micro robots with real-time MRI/fluoroscopy guidance and physics-informed AI control. Our platform enables closed-loop navigation, clot engagement, and retrieval within highly toruous vaculature using adaptive controllers and patient-specific digtial twins. Autonomous microrobot deployment enables rapid, local intervention for stroke thrombectomy. | For clinical translation, we seek partners with complementary expertise across neurovascular, caridovascular, and interventional domains. Key collaborators include neurosurgeons and interventional neuroradiologists for stroke thrombectomy workflows, interventional cardiologists for coronary navigation and clot retrieval, and vascular surgeons for broder endovascular applications. We also need clinical imaging specialists in MRI, and fluoroscopy, and emergency medicine clinicians. | TA2: Microbots, TA1: Endovascular Robotics |
| Pietro Valdastri | University of Leeds | p.valdastri@leeds.ac.uk | Leeds, UK | My lab, STORM Lab (https://www.stormlabuk.com/) is developing soft magnetic surgical robots to reach deep inside the human body. We have developed a robotic platform for painless and semi-autonomous colonoscopy that is now in use in humans. We are working on other several endoluminal robotic architectures based on magnetic soft continuum robots. | We work on autonomy of surgical and endoluminal robots. We would be keen to explore collaborations in this field to target the ARPA-H program goals | TA1: Endovascular Robotics, TA2: Microbots |
| Brett Zubiate | Carnegie Mellon University | bzubiate@andrew.cmu.edu | Pittsburgh, PA | The Robotics Institute at Carnegie Mellon University has focused on on several areas of research including surgical robotics development, automated, ultrasound scanning, novel sensor development and application of AI to complex tasks like triage and image guidance. | We are looking for interventionalists to work with on procedure development, animal model development and planning and execution of animal labs. | TA1: Endovascular Robotics, TA2: Microbots |
| Caleb Rucker | University of Tennessee | caleb.rucker@utk.edu | Knoxville, TN | Design and control and sensing of flexible tubular robots and steerable catheters. | Automation of medical image analysis and clinical expertise in thrombectomy. | TA1: Endovascular Robotics |
| Thomas Booth | KCL | thomas.booth@kcl.ac.uk | London, UK | Interventional neuroradiology robotic mechanical robotic thrombectomy with and without AI assistance. We have the academic expertise in the various domains necessary to deliver. | We are happy to work with a variety of partners. An established commercial endovascular robotic partner is particularly welcome. | TA1: Endovascular Robotics |
| Deepak Raina | Indian Institute of Technology Mandi | deepakraina@iitmandi.ac.in | Mandi, Himachal Pradesh, India | We develop autonomous endovascular robotic systems for trauma care procedures such as ultrasound-guided REBOA and central venous catheterization (CVC). Our research focuses on intelligent image-guided perception, control, and motion-planning algorithms to enable accurate, safe, end-to-end automation of these life-saving interventions. | We seek teaming partners with expertise in soft robotics, medical robot mechanism design, sensing and actuation, imaging systems, AI/ML for perception, and clinical translation. | TA1: Endovascular Robotics |
| Xiaoning Jiang | North Carolina State Universty | xjiang5@ncsu.edu | Raleigh, NC | Miniaturized piezoelectric ultrasound transducers and arrays for sensing, high frequency intravascular ultrasound imaging, intravascular sonothrombolysis, drug delivery, neural stimulation , tissue ablation, and histotripsy. Wearable ultrasound transducers and arrays for continuous health monitoring, neural modulation, therapy and assistive robots. Ultrasound catheters for imaging and therapy. | Autonomous control and robotic catheter expertise are needed for our team. In particular, robotic surgery, artificial intelligence powered autonomous control, catheter based sensing and actuation. | TA1: Endovascular Robotics, TA2: Microbots |
| Hamid Marvi | Arizona State University | hmarvi@asu.edu | Phoenix, AZ | Our team at Arizona State University develops magnetic medical robotics for minimally invasive interventions, including magnetically steerable catheters, electrodes, and microdevices. We specialize in nonlinear navigation using magnetic actuation and fiber-optic shape sensing, with demonstrated success in neurosurgery (epilepsy/PTSD), endoscopy, and thrombectomy through ex vivo and cadaveric validation. | We are particularly interested in teams with capabilities in large-animal studies, catheter/guidewire manufacturing, regulatory strategy, and commercialization to build a fully autonomous interventional platform. | TA1: Endovascular Robotics, TA2: Microbots |
| Yancy Diaz-Mercado | University of Maryland | yancy@umd.edu | College Park, MD | Our current research focus is on the control and state estimation of magnetic surgical tools via non-uniform magnetic fields for surgical tasks. | We are looking for partners with fabrication capabilities to develop magnetic micro robots with specialized functionality. | TA2: Microbots, TA1: Endovascular Robotics |
| Kimberly Hoang | Emory University School of Medicine | kimberly.bojanowski.hoang@emory.edu | Atlanta, GA | focused is currently on robotics applications in neurosurgery in general and specifically regarding brain tumors. I previously worked on a novel macro-scale benchtop prototype from inception, which sought to automate surgical resection of brain tumors utilizing robotics. The device focused on volumetric resection, which is an incremental step from most robotic applications that focus on stereotactic and trajectory-only applications | Overall goals is to outline and implement a surgical bundle or group of practical interventions to reduce surgical infections in all neurosurgical procedures to evaluate both system-wide effectiveness and adherence. | TA2: Microbots, TA1: Endovascular Robotics |
| Raj Ratwani | MedStar Health | raj.m.ratwani@medstar.net | Washington, D.C, DC | MedStar Health is the largest healthcare provider organization in the mid-Atlantic. We bring diverse clinical operations, expertise in all types of surgery, and the National Center for Human Factors in Healthcare. The human factors team brings usability and human-machine teaming expertise. | We are looking for industry partners that can drive solution development. | TA1: Endovascular Robotics, TA2: Microbots |
| Neal Sikka | GWU | nsikka@gwu.edu | Washington, DC | We are interested in the intersection of emergency medicine, AI and Robotics. | We are developing internal multidisciplinary teams and would welcome partners that compliment out expertise from other University settings as well as industry. | TA2: Microbots, TA1: Endovascular Robotics |
| John Galeotti | Carnegie Mellon University | jgaleotti@cmu.edu | Pittsburgh, PA | Robotics and AI, including novel sensors, medical computer vision, embodied AI, RL, snake robots, POCUS, etc., with prior applications in point-of-care autonomous life-saving interventions. | Complimentary expertise and resources, including hardware, sensors, animal/cadaver models, etc. | TA1: Endovascular Robotics, TA2: Microbots |
| Chuangchuang Sun | Villanova University | chuangchuang.sun@villanova.edu | Villanova, PA | I work on the learning, planning, navigation, and control for robots. I can possibly contribute to 2.2.1 Technical Area 1-A: Endovascular Interventional Robotic Systems: 4. Software to generate navigation and treatment plans based on pre-operative patient imaging, such as CT angiograms, and 2.2.3 Technical Area 1-B: Endovascular Interventional Simulation Environment: b. The planned autonomous navigation path. | Complementary to our areas in scope of this call. | TA1: Endovascular Robotics, TA2: Microbots |
| Aman | Nimble Surgical Incorporated | aman@nimblesurgical.com | Seattle, WA | Nimble Surgical is a young university spinout with proprietary mechanically actuated shape-transforming catheter technology that enables high DOF manual and robotic systems, ideal for a multi-functional project such as the AIR. Moreover, our scientific team is experienced in end-to-end hardware development, including sensing, actuation, control, and tip motion. | We are looking to collaborate for TA1-A with teams specializing in software capabilities for autonomous navigation, anatomy mapping, and imaging segmentation. | TA1: Endovascular Robotics |
| Salvador Pané Vidal | ETH Zürich | vidalp@ethz.ch | Multi-Scale Robotics Lab, Tannenstrasse 3, 8092, Zurich, Switzerland | The Multi-Scale Robotics Lab advances microrobotics for biomedical applications, developing intelligent magnetic machines and methods to fabricate and assemble these devices. A major milestone is a magnetic microrobotic drug delivery platform that balances biocompatibility, degradability, magnetic response, & payload, integrating clinical navigation, a release catheter, and dissolvable capsules with accurate navigation in vivo (Landers, Science 390.6774 (2025): 710-715.) | We seek clinical partners and researchers with expertise in minimally invasive, image-guided procedures and medical device use. Ideal collaborators are medical specialists experienced with device-based therapies who can co-design, test, and translate our microrobotic platform. | TA2: Microbots, TA1: Endovascular Robotics |
| Mahdi Imani | Northeastern University | m.imani@northeastern.edu | Boston, MA | Northeastern University develops advanced autonomy, learning, and safety frameworks for cyber-physical and medical systems. Our work includes adaptive control, multi-agent decision-making, uncertainty quantification, PAC-Bayesian safety, and symbolic/high-dimensional reasoning for robust autonomy in constrained biological and robotic environments. | We seek collaborators with expertise in microbot design, biocompatible actuation, medical imaging, and endovascular device development. We aim to provide autonomy, sensing-fusion, and safety frameworks while partnering with groups capable of hardware fabrication, clinical validation, and integrated testing in biological environments. | TA2: Microbots, TA1: Endovascular Robotics |
| David Gracias | Johns Hopkins University | dhgracias@gmail.com | Baltimore, MD | Untethered microgrippers and microinjectors for drug delivery and surgery | Companies, industrial and commercial partners | TA2: Microbots |
| Bijal Mehta | UCLA SOM | bmehta@mednet.ucla.edu | Los Angeles, CA | Synthetic Data Training; Generation of Live and Synthetic Data for Endovascular Thrombectomies | Hardware Partners; Work with hardware teams to develop training data for device training | TA1: Endovascular Robotics, TA2: Microbots |
| Sichen Yuan | The University of Alabama | sichen.yuan@ua.edu | Tuscaloosa, AL | My research focuses on structural development of endovascular robots by the tensegrity approach. My work also include millimeter scale fabrication and assembly, actuation and locomotion. | Fabrication and remote actuation at millimeter scale. Facilities for tissue experiments and animal trails. | TA1: Endovascular Robotics, TA2: Microbots |
| Junwei Li | Glia Medical Inc | gliamedicalinc@gmail.com | Irvine, CA | Glia Medical develops autonomous flow modulation system to treat intracerebral hemorrhage and hemorrhagic transformation of ischemic stroke. We build endovascular flow-modulation devices, micro-scale flow sensing, and closed-loop control systems for precise cerebral blood-flow regulation. Our team includes a former Medtronic Neurovascular Distinguished Engineer, the Chief Neuro-interventionalist and Chief Neurologist of NYC's largest stroke center, and a leading Prof. in cerebral flow sensing. | We seek partners with expertise in soft-robotic actuation, autonomous control algorithms, and high-fidelity physiological simulations and cerebrovascular models. Additional teaming interests include safety-of-autonomy frameworks, advanced sensor integration, AI-guided autonomy, and collaborators positioned to support clinical translation of autonomous neurovascular technologies. | TA2: Microbots, TA1: Endovascular Robotics |
| Howie Choset | Carnegie Mellon | choset@cs.cmu.edu | Pittsburgh, PA | Medical Robotics. Surgical Snake Robots. Ultrasound Imaging. Pill endoscopy | Medical doctors with similar interests | TA2: Microbots, TA1: Endovascular Robotics |
| Constantinos Zekios | Florida International University | kzekios@fiu.edu | Miami, FL, FL | Research in electromagnetics, computational models, 5G and 6G sensing systems, as well as microwave imaging, deployable sensors. | Partners with expertise in robotics, medical applications related to this solicitation, and deployable micro-structures. | TA2: Microbots, TA1: Endovascular Robotics |
| Alyssa Tanaka | AdventHealth | alyssa.tanaka@adventhealth.com | Orlando, FL | AdventHealth leads clinical innovation at the intersection of AI and robotics, advancing research in AI-driven decision support, surgical robotics evaluation, computer vision, image segmentation, and collaborative AI projects with academic partners. Our teams support rigorous clinical validation, de-identified data workflows, and translational research across multiple specialties. | We seek partners with strong technical expertise in autonomous robotics, micro-robotics, navigation, sensing, AI/ML modeling, and device engineering. AdventHealth provides the clinical expertise, real-world use cases, and diverse data collection sites required for testing, validation, and deployment of next-generation autonomous medical intervention systems. | TA1: Endovascular Robotics, TA2: Microbots |
| Andy Diepen | Caladan Robotics | andy@caladanrobotics.com | Calumet, MI, MI | We focus on specialized robotic applications with expertise in embedded control systems, non-standard control systems, sensor development and test system development. | We can support a team with development, testing, integration, and build activities. | TA1: Endovascular Robotics, TA2: Microbots |
| Hao Su | New York University | hao.su@nyu.edu | New York, NY | Our NYU team has developed versatile, highly compact endovascular robotic systems powered by novel miniature actuators. In parallel, we are advancing learning-in-simulation techniques for medical robots, work that has been published in Nature. We also lead the field in applying deep reinforcement learning to enable high levels of autonomy in neurovascular intervention. | medical imaging, fluoroscopy imaging and tracking, multimodal learning | TA1: Endovascular Robotics, TA2: Microbots |
| Balakrishna Haridas | Texas A&M University | bharidas@tamu.edu | College Station, TX | Minimally invasive pediatric and fetal surgery; Endovascular/catheter based interventions | Milliscale actuator and end effector design and fabrication; AI/ML applied to video feeds; | TA2: Microbots, TA1: Endovascular Robotics |
| Balakrishna Haridas | Shape Memory Medical Inc | bala@shapemem.com | San Jose, CA | Shape memory stimulus responsive polymers and foam based devices for endovascular embolization, thrombectomy, neurovascular embolization, abdominal aortic aneursym repair, thoracic aortic dissection repair. | Looking to partner with organizations that are working on robotic endovascular devices that can leverage our shape memory materials for vascular embolization and thrombectomy. | TA1: Endovascular Robotics, TA1: Endovascular Robotics |
| Xuan Wang | Virginia Tech | xuanw@vt.edu | Blacksburg, VA | We have expertise in small vision-language foundation models that can be deployed on the edge. We have a recent grant from Nvidia to develop and test the agentic capability of small foundation models on different edge devices (robots, IoT, wearables). We can support AI-enhanced robots for clinical applications. | We look to join a team that may need our AI computational expertise. | TA1: Endovascular Robotics, TA2: Microbots |
| Rishi Basdeo | Carnegie Mellon University | rbasdeo@andrew.cmu.edu | Pittsburgh, PA | Our research focuses on autonomous endovascular robotics through reinforcement learning for catheter/guidewire control, real-time extraction of tool configuration, and live registration between pre-operative anatomy and intraoperative imaging to support navigation. We also study human-factors challenges in spatial perception and interface design to inform safe, fully autonomous thrombectomy and embolization workflows. | We are looking for partners with strong capabilities in robotic hardware, clinical translation, and regulatory strategy. Our team has built custom instruments and sensing platforms for evaluating our methods, but would benefit from collaboration with groups more experienced in scalable device engineering, verification/validation, and clinical deployment. | TA1: Endovascular Robotics |
| Akshat Ghoshal | Accelint | akshat.ghoshal@soartech.com | Ann Harbor, MI | Accelint develops cognitive AI, autonomy, and human-machine teaming tools for DoD and healthcare. We specialize in modeling clinical reasoning, autonomous task-selection, and explainable decision logic for medical interventions. Our work includes cognitive architectures (DARPA ITM, SAVIOR), digital rehearsal environments, and AI systems that guide autonomous platforms toward safe, expert-aligned priorities. | Seeking a TA1-B Simulation Prime (or TA1-A Robotics team) needing a cognitive decision layer. We provide models of clinical reasoning, priority selection, and explainable autonomy that integrate with high-fidelity vascular simulators. Ideal partners offer endovascular physics engines, imaging-based navigation models, or hardware-in-the-loop testbeds where our cognitive layer guides and validates autonomous behavior. | TA1: Endovascular Robotics, TA1: Endovascular Robotics |
| Anthony Samir | Massachusetts General Hospital | asamir@mgh.harvard.edu | Cambridge, MA | AutonomUS Medical Technologies, Inc., is a Mass General Hospital/MIT spinout commercializing an advanced AI-enabled ultrasound-guided interventional system that automates vascular access. Using our system, a minimally trained user can perform arterial or venous cannulation. We therefore provide vascular access for endovascular robotics performers. Our company is funded by private investors, the DOD, and NIH. We have a full product development team and an FDA Breakthrough Device Designation. | We provide automated AI-enabled vascular access to partners working on endovascular robotics, including custom sheaths, complex access, etc. We presently have high TRL working systems that will require customization and refinement as part of this project. We have a substantial track record as a government performer, have excellent IP in this area, and have all the necessary engineering disciplines for credible product development. We have particularly strong AI and MechE capabilities. | TA1: Endovascular Robotics |
| David Miller | University of Oklahoma | Dmiller@ou.edu | Norman, OK | Developing surgical imaging technology that can visualize blood flow and tissue perfusion in real-time and continuously throughout surgery. | Engineers with expertise in developing surgical robotic systems | TA1: Endovascular Robotics, TA2: Microbots |
| Hava Siegelmann | UMass Amherst | hava.siegelmann@gmail.com | Amherst, MA | My lab is working on adaptive AI, lifelong learning, and distributed actions, that can fit very well small robotics | practical robotics | TA2: Microbots, TA2: Microbots |
| Shiren Wang | Texas A&M University | s.wang@tamu.edu | College Station, TX | My research is focused on micro/nano-robots for targeted delivery of biologics and gene therapies to deep or delicate tissues (such as brain or lung), enabling localized treatment of neurological disorders, pulmonary disease, or other conditions where conventional systemic delivery is ineffective or too toxic. | Seeking partners with complementary strengths to submit an ARPA-H AIR proposal, including: clinicians for hard-to-access organs; experts in robotic control, imaging, and micro/nano-fabrication; a hospital or academic medical center with trial infrastructure; regulatory and translational partners; and industry or startup collaborators for scalable manufacturing and commercialization pathways. | TA2: Microbots, TA2: Microbots |
| Yunus Alapan | University of Wisconsin - Madison | alapan@wisc.edu | Madison, WI | Our group works at the interface of robotics, microtechnology and bioengineering, developing soft micro-robots inspired by nature for healthcare applications. The overarching theme of our research is microrobots for size-matched and spatiotemporally resolved physical and biochemical manipulation of cells and tissues, with applications in targeted drug delivery and minimally-invasive interventions. | We are interested in partnering with teams working on clinical application of novel technologies. | TA2: Microbots, TA2: Microbots |
| Baoyun Ge | Georgia Institute of Technology | baoyun.ge@ece.gatech.edu | Atlanta, GA | My research focus is electric motors, actuators, electrostatics, magnetostatics, motion control | microfabrication, surgeon, robotic system design | TA2: Microbots, TA1: Endovascular Robotics |
| Fabian Landers | ETH Zurich | landersf@ethz.ch | Zurich, Switzerland | We are specialized in medical robotics and have recently developed a magnetically guided, fully dissolvable drug-delivery robot. (https://www.science.org/doi/10.1126/science.adx1708) | We are looking for expertise in toxicology and for medical professionals. | TA2: Microbots, TA1: Endovascular Robotics |
| Vincent Hingot | Resolve Stroke | Vincent.hingot@resolvestroke.com | Paris | Imaging and guidance | Rest | TA1: Endovascular Robotics, TA1: Endovascular Robotics |